| HIV− | HIV+ | P | HIV− >60 |
---|---|---|---|---|
Total N | 1417 | 308 | – | 1611 |
 | N (%) | N (%) |  | N (%) |
Postoperative complications | ||||
 Renal | 106 (7.5 %) | 28 (9.1 %) | 0.66 | 154 (9.6 %) |
 Cardiac | ≤10 (<1 %) | ≤10 (<3 %) | 0.38 | 68 (4.2 %) |
 Respiratory | 221 (15.6 %) | 56 (17.8 %) | 0.67 | 258 (16.0 %) |
 Liver | 0 | 0 | 0 | 0 |
 Gastrointestinal | 15 (1.0 %) | 0 | 0.43 | 29 (1.8 %) |
 Venous thromboembolism | 16 (1.2 %) | 0 | 0.42 | 30 (1.8 %) |
 Wound infection and intra-abdominal infection | 200 (14.1 %) | 39 (12.5 %) | 0.74 | 209 (13.0 %) |
 Sepsis | 40 (2.8 %) | ≤10 (<3 %) | 0.40 | 71 (4.4 %) |
 Postoperative hemorrhage | 19 (1.4 %) | 16 (5.1 %) | 0.05 | 46 (2.8 %) |
 Re-exploration | 0 | 0 | 0 | 0 |
 Any complication | 447 (31.5 %) | 107 (34.7 %) | 0.62 | 613 (38.1 %) |
 In-hospital mortality | 21 (1.5 %) | 0 (0 %) | 0.36 | 46 (2.9 %) |
Length of staya | ||||
 Median (IQR) | 8(6–12) | 9(7–14) | 0.13 | 9(7–14) |
 Extended LOS | 423(29.8 %) | 114 (36.9 %) | 0.26 | 644(40.0 %) |
Costb | ||||
 Median (IQR) | 20,124 (13,529–29,264) | 23,908 (15,915–34,378) | 0.08 | 19,618 (13,822–23,757) |
 Mean (95 % CI) | 26,588 (23,169–30,008) | 29,899 (23,115–36,683) | 0.39 | 27,948 (25,035–30,861) |